Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

COVID-19 can trigger a relapsing form of hair loss, requiring long-term treatment strategies.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

Type I interferons play a key role in the development of various skin diseases.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Ionizable lipid nanoparticles are the best for delivering gene-editing therapies.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Lactococcus lactis strain H61 may reduce some ageing symptoms.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Vitiligo and alopecia areata may have similar causes despite their differences.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.